The amyloid beta ion channel hypothesis of Alzheimer's disease

Neuropsychiatric Disease and Treatment

Volumn 3, Issue 5, 2007, Pages 597-612

  Shirwany, Najeeb A ^a   Payette, Daniel ^a   Xie, Jun ^a   Guo, Qing ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; A channels; Ion channel hypothesis

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; CALCIUM CHANNEL; CALCIUM ION; DONEPEZIL; FLURBIPROFEN; GLYCOSAMINOGLYCAN; HOMOTAURINE; ION CHANNEL; LY 450139; MEMANTINE; PRESENILIN 1; PRESENILIN 2; PROTEIN INHIBITOR; TAU PROTEIN; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN CELL; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CLINICAL TRIAL; DEMENTIA; DRUG MECHANISM; HUMAN; HYPOTHESIS; INCIDENCE; NERVE CELL MEMBRANE; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW; SENILE PLAQUE;

EID: 36049008767     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (147)

1. Alzheimer's Association. 2007. Alzheimer's Facts and Figures." [online] Accessed on March 1st, 2007. URL: http://www.alz.org/ alzheimers_disease_alzheimer_statistics.asp.
2. Aisen PS. 2005. The development of anti-amyloid therapy for Alzheimer's disease: from secretase modulators to polymerisation inhibitors. CNS Drugs, 19(12):989-96.
3. Akita T, Kuba K. 2000. Functional triads consisting of ryanodine receptors, Ca(2+) channels, and Ca(2+)-activated K(+) channels in bullfrog sympathetic neurons. Plastic modulation of action potential. J Gen Physiol, 116(5):697-720.
4. Arispe N. 2004. Architecture of the Alzheimer's A beta P ion channel pore. J Membr Biol, 197(1):33-48.
5. Arispe N, Pollard HB, et al. 1993. Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein (A beta P-(1-40)] in bilayer membranes. Proc Natl Acad Sci U S A, 90(22):10573-7.
6. 2+ interaction with Alzheimer amyloid beta protein calcium channels. Proc Natl Acad Sci U S A, 93(4):1710-5.
7. Arrasate M, Mitra S, et al. 2004. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature, 431(7010):805-10.
8. Arundine M, Tymianski M. 2004. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci, 61(6):657-69.
9. Atwood CS, Martins RN, et al. 2002. Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins. Peptides, 23(7):1343-50.
10. 2+-induced modification of the kinetics of A beta(1-42) channels. Am J Physiol Cell Physiol, 285(4): C873-80.
11. Behl C, Davis JB, et al. 1994. Amyloid beta peptide induces necrosis rather than apoptosis. Brain Res, 645(1-2):253-64.
12. Bezanilla F. 2000. The voltage sensor in voltage-dependent ion channels. Physiol Rev, 80(2):555-92.
13. Bhatia R, Lin H, et al. 2000. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity. Faseb J, 14(9):1233-43.
14. Blessed G, Tomlinson BE, et al. 1968. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry, 114(512):797-811.
15. 2+ homeostasis in peripheral neurones: implications for changes in function. Aging Cell, 6(3):285-96.
16. 2+ buffers and synaptic efficacy. Cell Calcium, 37(5):489-95.
17. 2+ channels and their role in neurotransmitter release. Cell Calcium, 24(5-6):307-23.
18. Caughey B, Lansbury PT. 2003. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci, 26:267-98.
19. Cook DG, Forman MS, et al. 1997. Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat Med, 3(9):1021-3.
20. Copani A, Sortino MA, et al. 2002. Erratic expression of DNA polymerases by beta-amyloid causes neuronal death. Faseb J, 16(14):2006-8.
21. Cruz JC, Tsai LH. 2004. Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol Med, 10(9):452-8.
22. De Ferrari GV, Charon MA, et al. 2003. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol Psychiatry, 8(2):195-208.
23. Denecker G, Vercammen D, et al. 2001. Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria. Cell Death Differ, 9(8):829-40.
24. Dickson DW 1997. The pathogenesis of senile plaques. J Neuropathol Exp Neurol, 56(4):321-39.
25. Durell SP, Guy HR, et al. 1994. Theoretical models of the ion channel structure of amyloid beta-protein. Biophys J, 67(6):2137-45.
26. Eckert A, Schindowski K, et al. 2001. Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice. Neurobiol Dis, 8(2):331-42.
27. Eguchi Y, Shimizu S, et al. 1997. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res, 57(10):1835-40.
28. 2+)-release channels. Trends Pharmacol Sci, 15(5):145-9.
29. Eliezer D. 2006. "Amyloid ion channels: a porous argument or a thin excuse?" J Gen Physiol, 128(6):631-3.
30. Fastbom J, Forsell Y, et al. 1998. Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Dis Assoc Disord, 12(1):14-7.
31. Fernandez-Vizarra P, Fernandez AP, et al. 2004. Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease. Histol Histopathol, 19(3):823-44.
32. Fraser S P, Suh YH, et al. 1997. Ionic effects of the Alzheimer's disease beta-amyloid precursor protein and its metabolic fragments: Trends Neurosci, 20(2):67-72.
33. Flurizan. 2005 Mar. Molecule of the month. MPC-7869. Drugs News Perspect, 18(2):141.
34. 2+ signaling in the brain. J Neurochem, 64(3):953-60.
35. Gever JR, Cockayne DA, et al. 2006. Pharmacology of P2X channels. Pflugers Arch, 452(5):513-37.
36. Gitter BD, CD, Li W, Dieckman DK, Bender MH, Nissen JS, Mabry TE, Yin T, Boggs LN, McClure DB, Little SP, Johnstone EM, Audia JE, May PC, Hyslop PA. 2004. Stereoselective Inhibition of Amyloid Beta Peptide Secretion by LY450139, A Novel Furictional Gamma Secretase Inhibitor. Neurobiol Aging, 25(Suppl 2):S571.
37. Glenner GG, Wong CW. 1984. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun, 120(3):885-90.
38. Golde TE, Eckman CB, et al. 2000. Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochim Biophys Acta, 1502(1):172-87.
39. Gorevic PD, Goni F, et al. 1986. Isolation and partial characterization of neurofibrillary tangles and amyloid plaque core in Alzheimer's disease: immumohistological studies. J Neuropathol Exp Neurol, 45(6):647-64.
40. Gotz J, Streffer JR, et al. 2004. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. Mol Psychiatry, 9(7):664-83.
41. Gouras GK, Tsai J, et al. 2000. Intraneuronal Abeta42 accumulation in human brain. Am J Pathol, 156(1):15-20.
42. Gravina. SA, Ho L, et al. 1995. Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem, 270(13):70134.
43. Greenfield JP, Tsai J, et al. 1999. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc Natl Acad Sci USA, 96(2):742-7.
44. Grynspan F, Griffin WB, et al. 1997. Calpains and calpastatin in SH-SY5Y neuroblastoma cells during retinoic acid-induced differentiation and neurite outgrowth: comparison with the human brain calpain system. J Neurosci Res, 48(3):181-91.
45. Guo Q, Fu W, et al. 1999. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med, 5(1):101-6.
46. Haass C, Koo EH, et al. 1992. Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature, 357(6378):500-3.
47. Haass C, Schlossmacher MG, et al. 1992. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature, 359(6393):322-5.
48. Hamill OP, Marty A, et al. 1981. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch, 391(2):85-100.
49. Hardy JA, Higgins GA. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science, 256(5054):184-5.
50. Harper SJ, Bilsland JG, et al. 1998. Mouse cortical neurones lacking APP show normal neurite outgrowth and survival responses in vitro. Neuroreport, 9(13):3053-8.
51. Hartmann J, Konnerth A. 2005. Determinants of postsynaptic Ca2+ signaling in Purkinje neurons. Cell Calcium, 37(5):459-66.
52. Hartmann T, Bieger SC, et al. 1997. Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat Med, 3(9):1016-20.
53. He X, Cooley K, et al. 2007. Apolipoprotein receptor 2 and X11 alpha/ beta mediate apolipoprotein E-induced endocytosis of amyloid-beta precursor protein and beta-secretase, leading to amyloid-beta production. J Neurosci, 27(15):4052-60.
54. Hirakura Y, Lin MC, et al. 1999. Alzheimer amyloid abetal-42 channels: effects of solvent, pH, and Congo Red. J Neurosci Res, 57(4):458-66.
55. 2+ channel diversity. Annu Rev Neurosci, 17:399-418.
56. Hollmann M, Heinemann S. 1994. Cloned glutamate receptors. Annu Rev Neurosci, 17:31-108.
57. Huang HM, Ou HC, et al. 2000. Antioxidants prevent amyloid peptide-induced apoptosis and alteration of calcium homeostasis in cultured cortical neurons. Life Sci, 66(19):1879-92.
58. Huang HM, Ou HC, et al. 2000. Blockage of amyloid beta peptide-induced cytosolic free calcium by fullerenol-1, carboxylate C60 in PC12 cells. Life Sci, 66(16):1525-33.
59. Iwatsubo T, Odaka A, et al. 1994. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron, 13(1):45-53.
60. Jarrett JT, Berger EP, et al. 1993. The C-terminus of the beta protein is critical in amyloidogenesis. Ann N Y Acad Sci, 695:144-8.
61. Jarrett JT, Berger EP, et al. 1993. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry, 32(18):4693-7.
62. Jo DG, Lee JY, et al. 2004. Induction of pro-apoptotic calsenilin/DREAM/ KChIP3 in Alzheimer's disease and cultured neurons after amyloid-beta exposure. J Neurochem, 88(3):604-11.
63. Jonas EA, Knox RJ, et al. 1997. Giga-ohm. seals on intracellular membranes: a technique for studying intracellular ion channels in intact cells. Neuron, 19(1):7-13.
64. Kamenetz F, Tomita T, et al. 2003. APP processing and synaptic function. Neuron, 37(6):925-37.
65. Katzman R, Saitoh T. 1991. Advances in Alzheimer's disease. Faseb J, 5(3):278-86.
66. 2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons. Biophys J, 73(1):67-75.
67. Keller BU, Hedrich R. 1992. Patch clamp techniques to study ion channels from organelles. Methods Enzymol, 207:673-81.
68. Klein WL, Stine WB Jr, et al. 2004. Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol Aging, 25(5):569-80.
69. Koh JY, Yang LL, et al. 1990. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res, 533(2):315-20.
70. Koo EH, Squazzo SL. 1994. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem, 269(26):17386-9.
71. Kowall NW, Beal MF, et al. 1991. An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. Proc Natl Acad Sci USA, 88(16):7247-51.
72. Leist M, Single B, et al. 1997. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med, 185(8):1481-6.
73. Lesne S, Ali C, et al. 2005. NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. J Neurosci, 25(41):9367-77.
74. Levites Y, Das P, et al. 2006. Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J Clin Invest, 116(1):193-201.
75. Lin H, Bhatia R, et al. 2001. Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology. Faseb J, 15(13):2433-44.
76. 2+-sensitive channel in reconstituted lipid vesicles. Biochemistry, 38(34):11189-96.
77. Lin X, Koelsch G, et al. 2000. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl A cad Sci USA, 97(4):1456-60.
78. Lorenzo A, Yankner BA. 1994. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci U S A, 91(25):12243-7.
79. Mann DM, Iwatsubo T, et al. 1996. Atypical amyloid (A beta) deposition in the cerebellum in Alzheimer's disease: an immunohistochemical study using end-specific A beta monoclonal antibodies. Acta Neuropathol (Berl), 91(6):647-53.
80. Mattson MP. 1998. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci, 21(2):53-7.
81. Mattson MP. 2007. Calcium and neurodegeneration. Aging Cell, 6(3):337-50.
82. Mattson MP, Cheng B, et al. 1992. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci, 12(2):376-89.
83. Mattson MP, Tomaselli KJ, et al. 1993. Calcium-destabilizing and neuro-degenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res, 621(1):35-49.
84. Mazzanti M, DeFelice LJ, et al. 1990. Ion channels in the nuclear envelope. Nature, 343(6260):764-7.
85. McHugh P, Turina M. 2006. Apoptosis and necrosis: a review for surgeons. Surg Infect (Larchmt), 7(1):5 3-68.
86. Mehta PD, Pirttila T, et al. 200 1. Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma ftom patients with Alzheimer disease. Neurosci Lett, 304(1-2):102-6.
87. Miranda S, Opazo C, et al. 2000. The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease. Prog Neurobiol, 62(6):633-48.
88. Morgan C, Colombres M, et al. 2004. Structure and function of amyloid in Alzheimer's disease. Prog Neurobiol, 74(6):3 23-49.
89. Neve RL, Dawes LR, et al. 1990. Genetics and biology of the Alzheimer amyloid precursor. Prog Brain Res, 86:257-67.
90. Oakley H, Cole SL, et al. 2006. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci, 26(40):10129-40.
91. Oddo S, Caccarno A, et al. 2003. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron, 39(3):409-21.
92. Paradis E, Douillard H, et al. 1996. Amyloid beta peptide of Alzheimer's disease downregulates Bel-2 and upregulates bax expression in human neurons. J Neurosci, 16(23):7533-9.
93. Pearson HA, Peers C. 2006. Physiological roles for amyloid beta peptides. J Physiol, 575(Pt 1):5-10.
94. Pike CJ, Burdick D, et al. 1993. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci, 13(4):1676-87.
95. Plant LD, Boyle JP, et al. 2003. The production of amyloid beta peptide is a critical requirement for the viability of central neurons. J Neurosci, 23(13):5531-5.
96. Price SA, Held B, et al. 1998. Amyloid beta protein increases Ca2+ currents in rat cerebellar granule neurones. Neuroreport, 9(3):539-45.
97. 2+ channel currents in primary cultures of rat cortical neurones by amyloid beta protein (1-40) is dependent on solubility status. Brain Res, 956(2):254-61.
98. Reyes AE, Chacon MA, et al. 2004. Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss. Am J Pathol, 164(6):2163-74.
99. 2+-sensitive channel. J Biol Chem, 273(22):13379-82.
100. Roher AE, Chaney MO, et al. 1996. Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem, 271(34):20631-5.
101. Savage MJ, Trusko SP, et al. 1998. Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol. ester. J Neurosci, 18(5):1743-52.
102. Schmitz C, Rutten BP, et al. 2004. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am J Pathol, 164(4):1495-502.
103. Selkoe DJ. 2001. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev, 81(2):741-66.
104. Selkoe DJ. 2001. Clearing the brain's amyloid cobwebs. Neuron, 32(2):177-80.
105. Selkoe DJ, Abraham CR, et al. 1986. Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J Neurochem, 46(6):1820-34.
106. Seubert P, Oltersdorf T, et al. 1993. Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature, 361(6409):260-3.
107. Simakova O, Arispe NJ. 2006. Early and late cytotoxic effects of external application of the Alzheimer's Abeta result from the initial formation and function of Abeta ion channels. Biochemistry, 45(18):5907-15.
108. Skovronsky DM, Doms RW, et al. 1998. Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. J Cell Biol, 141(4):1031-9.
109. Sokolov Y, Kozak JA, et al. 2006. Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure. J Gen Physiol, 128(6):637-47.
110. Stalder M, Phinney A, et al. 1999. Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am J Pathol, 154(6):1673-84.
111. Steinbach JP, Muller U, et al. 1998. Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice. Cell Death Differ, 5(10):858-66.
112. Takahashi RH, Milner TA, et al. 2002. Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol, 161(5):1869-79.
113. Talafous J, Marcinowski KJ, et al. 1994. Solution structure of residues 1-28 of the amyloid beta-peptide. Biochemistry, 33(25):7788-96.
114. Tamagno E, Robino G, et al. 2003. H2O2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK. Exp Neurol, 180(2):144-55.
115. Tamaoka A, Sawamura N, et al. 1997. Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease. J Neurol Sci, 148(1):41-5.
116. Thibault O, Gant JC, et al, 2007. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell, 6(3):307-17.
117. Toescu EC, Verkhratsky A. 2000. Parameters of calcium homeostasis in normal neuronal ageing. J Anat, 197 Pt 4:563-9.
118. Tomlinson BE, Blessed G, et al. 1968. Observations on the brains of non-demented old people. J Neurol Sci, 7(2):331-56.
119. Tomlinson BE, Blessed G, et al. 1970. Observations on the brains of demented old people. J Neurol Sci, 11 (3):205-42.
120. Tompkins MM, Hill WD. 1997. Contribution of somal Lewy bodies to neuronal death. Brain Res, 775(1-2):24-9.
121. Turner RS, Suzuki N, et al. 1996. Amyloids beta40 and beta42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. J Biol Chem, 271(15):8966-70.
122. Urbanc B, Cruz L, et al. 2002. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci U S A, 99(22):13990-5.
123. Vanterpool CK, Pearce WJ, et al. 2005. Advancing age alters rapid and spontaneous refilling of caffeine-sensitive calcium stores in sympathetic superior cervical ganglion cells. J Appl Physiol, 99(3):963-71.
124. Velez-Pardo C, Arroyave ST, et al. 2001. Ultrastructure evidence of necrotic neural cell death in familial Alzheimer's disease brains bearing presenilin-1 E280A.mutation. J Alzheimers Dis, 3(4):409-415.
125. Verkhratsky A, Shmigol A. 1996. Calcium-induced calcium release in neurones. Cell Calcium, 19(1):1-14.
126. Verkhratsky AT, EC. 1998. Integrative Aspects of Calcium Signalling. A. T. Verkhratsky, E.C London, Plenium Press428
127. Walsh DM, Selkoe DJ. 2004. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett, 11(3):213-28.
128. Wang R, Wang B, et al. 2006. Wild-type presenilin 1 protects against Alzheimer disease mutation-induced amyloid pathology. J Biol Chem, 281(22):15330-6.
129. Wenk GL. 2003. Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry, 64 Suppl 9:7-10.
130. Wenk GL. 2006. Neuropathologic changes in Alzheimer's disease: potential targets for treatment. J Clin Psychiatry, 67 Suppl 3:3-7; quiz 23.
131. White AR, Zheng H, et al. 1998. Survival of cultured neurons from amyloid precursor protein knock-out mice against Alzheimer's amyloid-beta toxicity and oxidative stress. J Neurosci, 18(16):6207-17.
132. Whitson JS, Selkoe DJ, et al. 1989. Amyloid beta protein enhances the survival of hippocampal neurons in vitro. Science, 243(4897):1488-90.
133. Wild-Bode C, Yamazaki T, et al. 1997. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42. J Biol Chem, 272(26):16085-8.
134. Wilson CA, Doms RW, et al. 1999. Intracellular APP processing and A beta production in Alzheimer disease. J Neuropathol Exp Neurol, 58(8):787-94.
135. Wilson CA, Doms RW, et al. 2002. Presenilins are not required for A beta 42 production in the early secretory pathway. Nat Neurosci, 5(9):849-55.
136. Winblad B, Poritis N. 1999. Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry, 14(2):135-46.
137. Wirths O, Multhaup G, et al. 2004. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptie - the first step of a fatal cascade. J Neurochem, 91(3):513-20.
138. Wirths O, Multhaup G, et al. 2002. Intraneuronal APP/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice. Brain Pathol, 12(3):275-86.
139. Wong CW, Quaranta V, et al. 1985. Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci USA, 82(24):8729-32.
140. Wuytack F, Raeymaekers L, et al. 2002. Molecular physiology of the SERCA and SPCA pumps. Cell Calcium, 32(5-6):279-305.
141. Xiao J, Perry G, et al. 1996. alpha-calcium-calmodulin-dependent kinase II is associated with paired helical filaments of Alzheimer's disease. J Neuropathol Exp Neurol, 55(9):954-63.
142. Xu H, Sweeney D, et al. 1997. Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc Natl Acad Sci U S A, 94(8):3748-52.
143. Yankner BA, Duffy LK, et al. 1990. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science, 250(4978):279-82.
144. Young JD, Cohn ZA, et al. 1986. The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities. Science, 233(4760):184-90.
145. Younkin SG. 1998. The role of A Beta 42 in Alzheimer's disease. J Physiol (Paris), 92:289-292.
146. Yuste R, Majewska A, et al. 2000. From form to function: calcium compartmentalization in dendritic spines. Nat Neurosci, 3(7):653-9.
147. Zheng H, Jiang M, et al. 1995. beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell, 81(4):525-31.